APOLIPOPROTEIN B IS RELATED TO METABOLIC SYNDROME INDEPENDENTLY OF LDL-CHOLESTEROL IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Lim, Y. -H. [1 ]
Yoo, S. Y. [1 ]
Chin, S. O. [1 ]
Lee, S. A. [1 ]
Koh, G. P. [1 ]
机构：
[1] Jeju Natl Univ Hosp, Internal Med, Jeju, South Korea
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70317-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO022
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [41] The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol
    Bouter, Kristien E. C.
    van Bommel, Erik J. M.
    Jansen, Hans
    van Harskamp, Dewi
    Schierbeek, Henk
    Ackermans, Mariette T.
    Serlie, Mireille J.
    Schimmel, Alinda W. M.
    Nieuwdorp, Max
    Dallinga-Thie, Geesje M.
    van Raalte, Daniel H.
    DIABETES OBESITY & METABOLISM, 2020, 22 (06): : 988 - 996
  • [42] LDL-cholesterol is not the best blood lipid predictor of CHD risk in type 2 diabetes
    Eliasson, B.
    Gudbjornsdottir, S.
    Eeg-Olofsson, K.
    Svensson, A. -M.
    Zethelius, B.
    Cederholm, J.
    DIABETOLOGIA, 2010, 53
  • [43] Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin
    Rabbani, Naila
    Chittari, Madhu Varma
    Bodmer, Charles W.
    Zehnder, Daniel
    Ceriello, Antonio
    Thornalley, Paul J.
    DIABETES, 2010, 59 (04) : 1038 - 1045
  • [44] LDL-cholesterol paradox in patients admitted with an acute coronary syndrome
    Timoteo, A. T.
    Ferreira, F.
    Miranda, F.
    Oliveira, J. A.
    Ferreira, M. L.
    Ferreira, R. C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 55 - 55
  • [45] LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome
    Pettersson, C.
    Karlsson, H.
    Stahlman, M.
    Larsson, T.
    Fagerberg, B.
    Lindahl, M.
    Wiklund, O.
    Boren, J.
    Fogelstrand, L.
    JOURNAL OF INTERNAL MEDICINE, 2011, 269 (03) : 306 - 321
  • [46] Sustained postprandial decrease in LDL-Cholesterol (LDL-C) in patients with type-2 diabetes mellitus (T2DM)
    Lund, S
    Petersen, M
    Frandsen, M
    Carstensen, B
    Parving, HH
    Dyerberg, J
    Jensen, T
    DIABETES, 2003, 52 : A213 - A213
  • [47] The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes
    Liatis, S.
    Tsapogas, P.
    Chala, E.
    Dimosthenopoulos, C.
    Kyriakopoulos, K.
    Kapantais, E.
    Katsilambros, N.
    DIABETES & METABOLISM, 2009, 35 (02) : 115 - 120
  • [48] COMPARISON OF METHODS FOR MEASURING LDL-CHOLESTEROL IN THE FASTING AND NONFASTING STATE IN PATIENTS WITH TYPE-2 DIABETES MELLITUS
    Lund, S.
    Petersen, M.
    Frandsen, M.
    Smidt, U.
    Parving, H. -H.
    Vaag, A.
    Jensen, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 79 - 79
  • [49] REPLY: Clinical Significance and Potential Mechanism of Discordance Between Apolipoprotein B and LDL-Cholesterol
    Wilkins, John T.
    Sniderman, Allan
    Lloyd-Jones, Donald M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (25) : 3024 - 3025
  • [50] Relationships of apolipoprotein B100 with the metabolic syndrome in Type 2 diabetes mellitus
    Relimpio, F
    Losada, F
    Pumar, A
    Mangas, MA
    Morales, F
    Astorga, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (03) : 199 - 207
12345